Interestingly, however, progesterone can reverse the adverse effects of IL-6 in PAH and block pSmad1-Id1/2 axis in IL-6-incubated PASMCs to improve vascular remodeling [168]. The gene discussed is IL6; the disease is pulmonary arterial hypertension.